Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Clinical trial NCT06397222 · RECRUITING
Trial details
- NCT number
- NCT06397222
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2027-04-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.